Guide to Sourcing Research Quality Compounds Safely
A Certificate of Analysis is only as reliable as the specific batch it represents. For many researchers, the primary obstacle isn’t finding a…
A Certificate of Analysis is only as reliable as the specific batch it represents. For many researchers, the primary obstacle isn’t finding a…
In the high-stakes environment of molecular research, a vendor’s guarantee is biologically irrelevant without raw chromatographic data to back it up….
A Certificate of Analysis from six months ago is mathematically irrelevant to the compound on your laboratory bench today. Inconsistent batch quality…
As of June 1, 2026, the European Medicines Agency mandates that any impurity exceeding 0.1% in synthetic peptides must be reported on analytical…
Analytical validity is not a product feature. It’s a procedural outcome of batch-specific verification. In a market where generic documentation is…
A single impurity in your starting material can invalidate months of in-vitro data. Most researchers realize that relying on a generic certificate of…
A Certificate of Analysis is only as reliable as the specific lot it represents. Following the full enforcement of the FDA’s Final Guidance on…
In laboratory research, purity is not a marketing claim; it is a verifiable analytical measurement that must be documented for every batch. You…
By mid-2026, the aggregate stockout rate for research peptides reached 12.2%, forcing many laboratories to choose between project delays and…
In an era of 300% increases in FDA enforcement, the “research use only” label is no longer a shield for sub-standard analytical practices. If your…